Drug Trial Radar · NCT07290036
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
392
Planned (sponsor's estimate)
Start
Dec 10, 2025
Primary completion
May 18, 2028
Study completion Sep 14, 2028
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
Conditions
- Psoriatic Arthritis
- Axial Spondyloarthritis
Interventions
Bimekizumab regimen 1 ivDrug
Participants will receive bimekizumab (BKZ) at pre-specified time points.
Bimekizumab regimen 2 ivDrug
Participants will receive bimekizumab (BKZ) at pre-specified time points.
Bimekizumab regimen 3 scDrug
Participants will receive bimekizumab (BKZ) at pre-specified time points.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Steady-state Trough Concentration (Ctrough,ss) at Week 16Time frame: Week 16
Locations
65 sites in 6 countries. Site status is shown where the registry gives one.
Pa0019 114
Peoria, Arizona · Recruiting
Pa0019 127
Apple Valley, California · Recruiting
Pa0019 111
Covina, California · Recruiting
Pa0019 119
Fullerton, California · Recruiting
Pa0019 117
Riverside, California · Recruiting
Pa0019 125
San Leandro, California · Recruiting
Pa0019 126
Temecula, California · Recruiting
Pa0019 141
Upland, California · Recruiting
Pa0019 120
Whittier, California · Recruiting
Pa0019 128
Whittier, California · Recruiting
Pa0019 123
Fort Collins, Colorado · Recruiting
Pa0019 143
Ormond Beach, Florida · Recruiting
Pa0019 113
South Miami, Florida · Recruiting
Pa0019 133
Zephyrhills, Florida · Recruiting
Pa0019 132
Chicago, Illinois · Recruiting
Pa0019 134
Lansing, Michigan · Recruiting
Pa0019 140
West Long Branch, New Jersey · Recruiting
Pa0019 131
Albuquerque, New Mexico · Recruiting
Pa0019 144
Vandalia, Ohio · Recruiting
Pa0019 115
Duncansville, Pennsylvania · Recruiting
Pa0019 142
Rock Hill, South Carolina · Recruiting
Pa0019 116
Jackson, Tennessee · Recruiting
Pa0019 138
Murfreesboro, Tennessee · Recruiting
Pa0019 129
Baytown, Texas · Recruiting
Pa0019 136
Colleyville, Texas · Recruiting
Pa0019 135
Mesquite, Texas · Recruiting
Pa0019 124
Plano, Texas · Recruiting
Pa0019 121
Bellevue, Washington · Recruiting
Pa0019 145
Spokane, Washington · Recruiting
Pa0019 130
Beckley, West Virginia · Recruiting
Pa0019 204
Lovech, Bulgaria · Recruiting
Pa0019 205
Pleven, Bulgaria · Recruiting
Pa0019 201
Plovdiv, Bulgaria · Recruiting
Pa0019 202
Plovdiv, Bulgaria · Recruiting
Pa0019 203
Plovdiv, Bulgaria · Recruiting
Pa0019 705
Brno, Czechia · Recruiting
Pa0019 703
Hlučín, Czechia · Recruiting
Pa0019 704
Ostrava, Czechia · Recruiting
Pa0019 702
Uherské Hradiště, Czechia · Recruiting
Pa0019 305
Berlin, Germany · Recruiting
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.